Cargando…

Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology

BACKGROUND: In middle income countries the number of trained health technology assessment specialists is limited and the public budget for health technology assessment is considerably lower compared to developed countries. These countries therefore must develop their own solutions to improve the qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Inotai, András, Pékli, Márta, Jóna, Gabriella, Nagy, Orsolya, Remák, Edit, Kaló, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465229/
https://www.ncbi.nlm.nih.gov/pubmed/22999574
http://dx.doi.org/10.1186/1472-6963-12-332
_version_ 1782245532854386688
author Inotai, András
Pékli, Márta
Jóna, Gabriella
Nagy, Orsolya
Remák, Edit
Kaló, Zoltán
author_facet Inotai, András
Pékli, Márta
Jóna, Gabriella
Nagy, Orsolya
Remák, Edit
Kaló, Zoltán
author_sort Inotai, András
collection PubMed
description BACKGROUND: In middle income countries the number of trained health technology assessment specialists is limited and the public budget for health technology assessment is considerably lower compared to developed countries. These countries therefore must develop their own solutions to improve the quality and efficiency of health technology assessment implementation in reimbursement decisions. Our study aimed to develop a scientifically rigorous and detailed appraisal checklist for economic evaluations of pharmaceuticals in the single health technology assessment process. METHODS: The research design entailed a review of economic evaluations, submitted for reimbursement of pharmaceuticals, by two independent academic reviewers to identify the most common methodological problems. Fifty economic evaluations submitted in 2007-2008, randomly selected by the Health Technology Assessment Office served as data sources. The new checklist was developed by an iterative working process: first by assessing ten economic evaluations, then improving the checklist by generating new question items, then employing the improved checklist to assess the next ten economic evaluations. After appraising 25 documents, the reviewers reconciled their opinions and improved the checklist with the researchers of the Health Technology Assessment Office during an expert panel discussion. The reviewers scrutinized the second 25 economic evaluations, after which the expert panel finalized the checklist with consensus. RESULTS: The final checklist consists of 91 yes or no questions in 11 main topics concerning comparator selection, efficacy, effectiveness, costs, sensitivity analysis, methodological approach, transparency, and interpretation of results. The new checklist is based on current Hungarian evaluation practice. As the published checklist will be part of the official single health technology assessment process of pharmaceuticals, submitters will be able to assure the quality of their economic evaluation. CONCLUSIONS: The transparent critical appraisal method should improve the consistency of pharmaceutical reimbursement decisions and facilitate the utilization of economic evaluations in other fields of health care decision-making in other Central-Eastern European countries.
format Online
Article
Text
id pubmed-3465229
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34652292012-10-06 Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology Inotai, András Pékli, Márta Jóna, Gabriella Nagy, Orsolya Remák, Edit Kaló, Zoltán BMC Health Serv Res Research Article BACKGROUND: In middle income countries the number of trained health technology assessment specialists is limited and the public budget for health technology assessment is considerably lower compared to developed countries. These countries therefore must develop their own solutions to improve the quality and efficiency of health technology assessment implementation in reimbursement decisions. Our study aimed to develop a scientifically rigorous and detailed appraisal checklist for economic evaluations of pharmaceuticals in the single health technology assessment process. METHODS: The research design entailed a review of economic evaluations, submitted for reimbursement of pharmaceuticals, by two independent academic reviewers to identify the most common methodological problems. Fifty economic evaluations submitted in 2007-2008, randomly selected by the Health Technology Assessment Office served as data sources. The new checklist was developed by an iterative working process: first by assessing ten economic evaluations, then improving the checklist by generating new question items, then employing the improved checklist to assess the next ten economic evaluations. After appraising 25 documents, the reviewers reconciled their opinions and improved the checklist with the researchers of the Health Technology Assessment Office during an expert panel discussion. The reviewers scrutinized the second 25 economic evaluations, after which the expert panel finalized the checklist with consensus. RESULTS: The final checklist consists of 91 yes or no questions in 11 main topics concerning comparator selection, efficacy, effectiveness, costs, sensitivity analysis, methodological approach, transparency, and interpretation of results. The new checklist is based on current Hungarian evaluation practice. As the published checklist will be part of the official single health technology assessment process of pharmaceuticals, submitters will be able to assure the quality of their economic evaluation. CONCLUSIONS: The transparent critical appraisal method should improve the consistency of pharmaceutical reimbursement decisions and facilitate the utilization of economic evaluations in other fields of health care decision-making in other Central-Eastern European countries. BioMed Central 2012-09-21 /pmc/articles/PMC3465229/ /pubmed/22999574 http://dx.doi.org/10.1186/1472-6963-12-332 Text en Copyright ©2012 Inotai et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Inotai, András
Pékli, Márta
Jóna, Gabriella
Nagy, Orsolya
Remák, Edit
Kaló, Zoltán
Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
title Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
title_full Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
title_fullStr Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
title_full_unstemmed Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
title_short Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
title_sort attempt to increase the transparency of fourth hurdle implementation in central-eastern european middle income countries: publication of the critical appraisal methodology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465229/
https://www.ncbi.nlm.nih.gov/pubmed/22999574
http://dx.doi.org/10.1186/1472-6963-12-332
work_keys_str_mv AT inotaiandras attempttoincreasethetransparencyoffourthhurdleimplementationincentraleasterneuropeanmiddleincomecountriespublicationofthecriticalappraisalmethodology
AT peklimarta attempttoincreasethetransparencyoffourthhurdleimplementationincentraleasterneuropeanmiddleincomecountriespublicationofthecriticalappraisalmethodology
AT jonagabriella attempttoincreasethetransparencyoffourthhurdleimplementationincentraleasterneuropeanmiddleincomecountriespublicationofthecriticalappraisalmethodology
AT nagyorsolya attempttoincreasethetransparencyoffourthhurdleimplementationincentraleasterneuropeanmiddleincomecountriespublicationofthecriticalappraisalmethodology
AT remakedit attempttoincreasethetransparencyoffourthhurdleimplementationincentraleasterneuropeanmiddleincomecountriespublicationofthecriticalappraisalmethodology
AT kalozoltan attempttoincreasethetransparencyoffourthhurdleimplementationincentraleasterneuropeanmiddleincomecountriespublicationofthecriticalappraisalmethodology